Question 1

What are the potential benefits of participating in this trial for my CMV prevention?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maribavir for Prevention of CMV After Stem Cell Transplants clinical trial (NCT00223925). Contact the study team or your healthcare provider for specific answers.

Question 2

How does maribavir compare to other treatments I might be offered?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maribavir for Prevention of CMV After Stem Cell Transplants clinical trial (NCT00223925). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from maribavir?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maribavir for Prevention of CMV After Stem Cell Transplants clinical trial (NCT00223925). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maribavir for Prevention of CMV After Stem Cell Transplants clinical trial (NCT00223925). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the duration of the treatment, and how will it affect my daily life?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maribavir for Prevention of CMV After Stem Cell Transplants clinical trial (NCT00223925). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks involved in participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Maribavir for Prevention of CMV After Stem Cell Transplants clinical trial (NCT00223925). Contact the study team or your healthcare provider for specific answers.

What this study is about